Centre Hospitalier Fleyriat; Oncologie/Hematologie
About Centre Hospitalier Fleyriat; Oncologie/Hematologie
"Le Centre Hospitalier de Bourg-en-Bresse (CHB) est un établissement de Médecine-Chirurgie-Obstétrique qui compte plus de 900 lits et places, plus de 2 419 professionnels répartis au sein de ses 7 pôles d’activités médicales : Médecine, Chirurgie, Cancérologie, Soins Critiques, Mère-Enfant, Transversal & Support et Gériatrie. Chaque année, le CHB gère également près de 300 000 appels entrants au SAMU 01, plus de 137 000 consultations (hors imagerie, CSP, urgences), plus de 47 000 passages aux Urgences, plus de 12 000 patients sont reçus au bloc opératoire. 120 résidents sont accueillis en USLD et 169 en EHPAD. www .ch-bourg-en-bresse.fr LinkedIN : Centre hospitalier de Bourg-en-Bresse"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Clinical Trials at Centre Hospitalier Fleyriat; Oncologie/Hematologie
During the past decade, Centre Hospitalier Fleyriat; Oncologie/Hematologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on
average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
2010-09-30
2015-06-30
Completed
210
An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years
2011-03-28
2012-11-16
Completed
160
An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)
2012-03-05
2016-07-20
Completed
402
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Study to Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 Years
2013-06-11
2019-07-17
Completed
114
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
2013-07-25
2018-03-20
Completed
279
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Fleyriat; Oncologie/Hematologie"
#1 collaborator was "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Centre Hospitalier Fleyriat; Oncologie/Hematologie
According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" are
"Breast Cancer" (5 trials), "Colorectal Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" in a lesser frequency.
Clinical Trials Intervention Types at Centre Hospitalier Fleyriat; Oncologie/Hematologie
Most popular intervention types in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Trastuzumab" (4 trials), "Pertuzumab" (2 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Hospitalier Fleyriat; Oncologie/Hematologie
The vast majority of trials in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" are
6 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Centre Hospitalier Fleyriat; Oncologie/Hematologie
Currently, there are NaN active trials in "Centre Hospitalier Fleyriat; Oncologie/Hematologie".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Centre Hospitalier Fleyriat; Oncologie/Hematologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre Hospitalier Fleyriat; Oncologie/Hematologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".